Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale 10% owner sold 700 shares at $25.11 ($17,577)
  2. 4 Planned sale Director sold 18,000 shares at $24.66 ($443,916)
  3. 4 Open-market sale 10% owner sold 96,952 shares at an average $25.17 ($2,440,652)
  4. 4 Open-market sale 10% owner sold 9,902 shares at $25.18 ($249,302)
  5. 4 Open-market sale 10% owner sold 183,326 shares at an average $25.56 ($4,685,659)
  6. 4 Open-market sale 10% owner sold 164,102 shares at an average $26.75 ($4,389,798)
  7. 4 Planned sale Chief Medical Officer sold 5,000 shares at $25.95 ($129,727)
  8. 4 Open-market sale 10% owner sold 39,562 shares at an average $27.32 ($1,080,730)
  9. 4 Planned sale Chief Administrative Officer sold 2,500 shares at $25.67 ($64,175)
  10. 4 Planned sale Director sold 3,500 shares at $25.67 ($89,845)
  11. 4 Open-market sale 10% owner sold 274,451 shares at an average $26.46 ($7,262,829)
  12. 4 Grant or award Director acquired 6,027 shares (grant or award)
  13. 4 Grant or award Director acquired 6,027 shares (grant or award)
  14. 4 Grant or award Director acquired 6,027 shares (grant or award)
  15. 4 Grant or award Director acquired 6,027 shares (grant or award)
  16. 4 Grant or award Director acquired 6,027 shares (grant or award)
  17. 4 Grant or award Director acquired 6,027 shares (grant or award)
  18. 4 Grant or award Director acquired 6,027 shares (grant or award)
  19. 4 Grant or award Director acquired 6,027 shares (grant or award)
  20. 4 Grant or award Director acquired 6,027 shares (grant or award)

Page 7 of 25 · 491 filings